article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Clinical trials technology company Saama has hired Dr Clinton White as its new chief delivery officer. We’ve rounded up some highlights below. Digital therapeutics hires.

article thumbnail

Cognoa preps FDA filing for digital autism diagnostic

pharmaphorum

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. Cognoa has revealed however that the trial suggests the app is highly accurate across males and females as well as ethnic and racial backgrounds.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Applied Virtual Reality in Healthcare: A comprehensive book on medical XR

pharmaphorum

Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. We will see a new generation of better assessments, which will empower better research,” Greenleaf said. About the interviewee.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. They also understand how to do clinical trial design,” Gani states.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Clinical trials get more and more digitalised. Aging in place’ becomes more commonplace. Integration of telehealth strategy into commercial models.

article thumbnail

Drug discovery predictions: Analysis and insight 

Drug Discovery World

Here, Thomas reflects specifically on Anita Cooper’s prediction relating to the importance of clinical trials. . Following the launch of Protas, DDW spoke with Protas Chief Executive, Professor Sir Martin Landray, who echoed Cooper’s emphasis on the importance of clinical trial design.